AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹18,039 Cr | ₹14,682 Cr | ₹12,199 Cr | ₹11,494 Cr | ₹8,156 Cr |
What is the latest Total Current Liabilities ratio of AUROBINDO PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹18,039 Cr |
| Mar2025 | ₹14,682 Cr |
| Mar2024 | ₹12,199 Cr |
| Mar2023 | ₹11,494 Cr |
| Mar2022 | ₹8,156 Cr |
How is Total Current Liabilities of AUROBINDO PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹18,039 Cr | 22.86 | |
| Mar2025 | ₹14,682 Cr | 20.36 | |
| Mar2024 | ₹12,199 Cr | 6.14 | |
| Mar2023 | ₹11,494 Cr | 40.92 | |
| Mar2022 | ₹8,156 Cr | - | |
Compare Total Current Liabilities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹96,839.8 Cr | -0.1% | 0.8% | 56.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -0.1% |
0.8% |
56.3% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses